.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
In addition to growth monitoring, recent research by Lauer JM et al. highlights the impact of SQ-LNS pediatric nutrition on child development. Specifically, the team conducted an 18-month trial in Lusaka, Zambia, to evaluate intestinal health. They investigated whether small-quantity lipid-based nutrient supplements (SQ-LNS) could reduce environmental enteric dysfunction (EED) and systemic inflammation. While experts know SQ-LNS improves growth and survival, the specific biological pathways remain unclear.
During the trial, the study analyzed 302 children aged 27 to 35 months using serum biomarkers and rectal swabs. Moreover, researchers looked for changes in gut microbiome alpha diversity, beta diversity, and systemic inflammation. Furthermore, they measured markers such as intestinal fatty acid-binding protein (I-FABP) and C-reactive protein. However, the results showed no broad changes in intestinal health markers. Consequently, the supplement did not significantly alter the overall microbial community composition.
Therefore, these findings suggest that the clinical benefits of SQ-LNS likely come from increased nutrient availability. Although the study found a lower abundance of Enterococcus in the intervention group, it detected no other major shifts. As a result, this evidence implies that doctors should focus on nutritional density for growth outcomes. Ultimately, managing EED might require different environmental or clinical interventions beyond standard lipid-based supplements.
SQ-LNS provides essential micronutrients and a small caloric boost to prevent stunting and wasting in young children. While it supports linear growth, it may not directly resolve intestinal inflammation.
According to the Zambian study, 18 months of supplementation did not lead to significant changes in gut microbial diversity or overall community structure in children.
Researchers used the Multiple-Micronutrient and Environmental Enteric Dysfunction Assessment Tool (MEEDAT) to measure soluble CD14 and intestinal fatty acid-binding protein (I-FABP).
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Lauer JM et al. Gut Microbiome and Environmental Enteric Dysfunction Are Unchanged by 18 Months of Small-Quantity Lipid-Based Nutrient Supplementation among Young Children in Lusaka, Zambia. Br J Nutr. 2026 Jun 22. doi: 10.1017/S0007114526107818. PMID: 42324602.
2. Fink G et al. The impact of home-installed growth charts and small-quantity lipid-based nutrient supplements (SQ-LNS) on child growth in Zambia: a four-arm parallel open-label cluster randomised controlled trial. BMJ Glob Health. 2024;9(8):e015438.
3. Dewey KG et al. Small-quantity lipid-based nutrient supplements for the prevention of child undernutrition: a primary care-based intervention. Matern Child Nutr. 2021;17 Suppl 1:e13227.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study in Lusaka, Zambia, found that 18 months of small-quantity lipid-based nutrient supplementation (SQ-LNS) did not significantly change the gut microbiome or markers of environmental enteric dysfunction in children, suggesting growth benefits arise from nutrient availability instead.
2 months ago
A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
